ストックスクリーナーアプリを入手
3.0391
2.40%
-0.0809
前日終値:
$3.12
開ける：
$3.11
24時間の取引高:
128.11K
Relative Volume:
0.14
時価総額：
$144.01M
収益：
$144.98M
当期純損益:
$-104.19M
株価収益率:
-1.2839
EPS:
-2.367
ネットキャッシュフロー:
$-82.90M
1週間 パフォーマンス:
+17.57%
1か月 パフォーマンス:
-23.30%
6か月 パフォーマンス:
-47.14%
1年 パフォーマンス:
-37.09%
1日の値動き範囲:
$3.0105
$3.11
1週間の範囲:
$2.65
$3.25
52週間の値動き範囲:
$2.15
$8.77
Quanterix Corp Stock (QTRX) Company Profile
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
3.045 | 139.99M | 144.98M | -104.19M | -82.90M | -2.367 |
ABT
Abbott Laboratories
|
116.28 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.39 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
93.03 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.69 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.79 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-11 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2024-02-01 | 開始されました | Scotiabank | Sector Outperform |
| 2023-09-25 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-08-08 | アップグレード | SVB Securities | Market Perform → Outperform |
| 2023-05-23 | アップグレード | Goldman | Neutral → Buy |
| 2022-08-15 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-08-09 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-08-09 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-03-02 | アップグレード | Goldman | Sell → Neutral |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-04 | 開始されました | Goldman | Sell |
すべてを表示
Quanterix Corp (QTRX) 最新ニュース
Quanterix (QTRX) director adds 3,955 shares via RSU vest - Stock Titan
Quest Diagnostics Executive Recruited to Quanterix’s Senior Management Team - Medical Product Outsourcing
Quanterix (QTRX) CCO files initial ownership report with no shares - Stock Titan
Quanterix (QTRX) director now holds 162,401 shares - Stock Titan
Quanterix (QTRX) CTO converts RSUs, withholds shares for taxes - Stock Titan
Quanterix (QTRX) Q2 2026 Earnings Call Transcript - The Globe and Mail
QTRX Maintains Rating by Canaccord Genuity -- Price Target Lowered to $3.00 - GuruFocus
Quanterix (NASDAQ:QTRX) Price Target Cut to $3.00 by Analysts at Canaccord Genuity Group - MarketBeat
Canaccord cuts Quanterix stock price target on weak Q2 results - Investing.com
GSA Capital Partners LLP Makes New Investment in Quanterix Corporation $QTRX - MarketBeat
Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test - sharewise.com
Quanterix (NASDAQ:QTRX) Lowered to Sell Rating by Wall Street Zen - MarketBeat
Quanterix Stock Price Forecast. Should You Buy QTRX? - StockInvest.us
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Quanterix Corp (QTRX) director-linked trusts buy 99,400 shares in open market - Stock Titan
Quanterix Corp (QTRX) Stock News Today - TradingKey
Quanterix Corp (QTRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Quanterix at canaccord growth conference: sales reset aims to lift growth - Investing.com
Quanterix (QTRX) Earnings Shake Up The Story As Fair Value Still Sits Higher - Yahoo Finance
QTRX Maintains Hold Rating -- Price Target Lowered to $3.00 by T - GuruFocus
TD Cowen Issues Pessimistic Forecast for Quanterix (NASDAQ:QTRX) Stock Price - MarketBeat
Quanterix earnings missed by $0.64, revenue fell short of estimates - Investing.com Canada
Quanterix Corp (QTRX) (Q2 2026) Earnings Call Highlights: Revenue Miss and Guidance Cut Amid Market Softness - GuruFocus
Earnings call transcript: Quanterix Q2 2026 revenue miss sends shares down 43% - Investing.com South Africa
Quanterix Corp (QTRX) (Q2 2026) Earnings Call Highlights: Revenue Miss and Guidance Cut Amid ... - Yahoo Finance
Quanterix (NASDAQ:QTRX) Drops 39% After Outlook Revision Pushes Breakeven Back to 2027 - TechStock²
Quanterix Q2 Earnings Call Highlights - MarketBeat
Quanterix Cuts 2026 Revenue Outlook as Commercial Challenges Delay Cash-Flow Break-Even - Yahoo Finance
Quanterix Q2 2026 slides: revenue miss prompts guidance cut - Investing.com
Quanterix Corp (QTRX) Misses Q2 Earnings Estimates with EPS at - GuruFocus
Quanterix appoints Jim Gute as chief commercial officer - Investing.com
QTRX Looks 65.9% Undervalued on GF Value™ Despite Revenue Miss - GuruFocus
Quanterix Q2 adjusted EPS misses estimates, sales rise 34% - scanx.trade
Form 8K Quanterix Corp For: 10 August By Investing.com - Investing.com Nigeria
Quanterix (NASDAQ:QTRX) Announces Quarterly Earnings Results - MarketBeat
Quanterix Corp 2026: Revenue $32.91M, EPS ($1.04) — 10-Q Summary - TradingView
Quanterix (QTRX) boosts revenue as Alzheimer’s bets rise amid big write-downs - Stock Titan
Quanterix Corporation Revises Financial Guidance for the Year 2026 - marketscreener.com
Form 8K Quanterix Corp For: 10 August - Investing.com India
Quanterix Q2 2026 earnings: Revenue rises 34% as outlook is cut - TradingKey
Quanterix Q2 revenue rises to $32.9 million as 2026 outlook cut - Quiver Quantitative
Quanterix Corporation Announces Appointment of Jim Gute as Chief Commercial Officer - marketscreener.com
Quanterix Releases Financial Results for the Second Quarter of 2026 - Yahoo Finance
Earnings To Watch: Quanterix Corp (QTRX) Q2 2026 -- GF Value Sees 253% Upside - GuruFocus
QUANTERIX Q2 2026 Earnings Preview: Recent $QTRX Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Quanterix CEO to give company update in Aug. 12 webcast - Stock Titan
Quanterix Corp (NASDAQ: QTRX) CTO reports 130 RSUs vesting, 39 shares withheld - Stock Titan
Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026 - Caledonian Record
Quanterix Corp expected to post a loss of 46 cents a shareEarnings Preview - TradingView
Quanterix (QTRX) to Post Earnings on Thursday - MarketBeat
Quanterix Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Quanterix Corp (QTRX) 財務データ
収益
当期純利益
現金流量
EPS
1.36%
大文字化:
|
ボリューム (24 時間):